General discussion, page-13226

joel and the bod are not physically running these trials those news items shouldnt not have held up progress. no current trials are lengthy phase 3 trials and all have been running over 12 months. face value it feels like they invested too much time into the ndq listing, which has not born the fruits it was expected to. we have no guidance on how this acquisition fits into the current pipleine and if the plan is to expand it, it doesnt feel like they have the time for that. the options feel like a tie over for delays and are most certainly a seudo cr because the ndq cr fell through for whatever reason. only saving grace is that the osa results are amazing. full report cant come soon enough